Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Single-blind, Cross-over Study of Loteprednol Etabonate in Adults Undergoing Bilateral Cataract Surgery

NCT03531697 is registered in ClinicalTrials.gov with Sandoz as lead sponsor.

NCT NCT03531697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03531697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Single-blind, Cross-over Study of Loteprednol Etabonate in Adults Undergoing Bilateral Cataract Surgery
Lead sponsor
Sandoz
Phase
Phase 1
Overall status
Completed
Start date
April 26, 2018
Completion date
October 7, 2019
Enrollment
381 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammation following ocular surgery